Trial intelligence / Profile preview

Prucalopride for Postoperative Ileus in Colorectal Surgery

NCT02947269Phase 3Completed

Sponsor
The University of Auckland
Start
Oct 2017
Primary completion
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of prucalopride in postoperative ileus (POI) (2 arms), sponsored by The University of Auckland. Primary endpoint: Time until recovery of gastrointestinal function. Started Oct 2017; status: completed.

02

Drugs

prucalopride
03

Conditions

postoperative ileus (POI)

Beyond the preview

Go deeper on NCT02947269.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02947269.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call